The present disclosure relates generally to the field of pharmaceuticals.Specifically, the present disclosure is directed to a composition for inhibition ofIRE1 for management of epilepsy comprising 7-Hydroxy-4-methyl-2-oxo-2H-chromene-8-carbaldehyde.

Inventors

Thakur Gurjeet Singh, Shareen Singh

Patent File Number - 202111022918        Patent File Date - 22/05/2021